Risk-Taking: Clinical Trials

3 trials for Risk-Taking, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3

Follow Risk-Taking: new trials by email Literature Review of Risk-Taking trials Research Report on Risk-Taking

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response
Naltrexone, Placebo - Eye Tracking, Gambling Disorder
Phase 2UnknownUniversity of Sao Paulo402021-06-012021-02-04
Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder
Naloxone hydrochloride, Placebo - Pathological Gambling, Gambling Disorder
Phase 2UnknownFinnish Institute for Health and Welfare1262018-02-222019-07-16
Pro-Change Population Health Solution
PCPHC, Usual care - Risk Behavior
Phase 2UnknownPro-Change Behavior Systems7802016-05-012016-06-02

Narrower conditions

Gambling (2)  ·  Patient Participation (1)

Broader conditions

Behavior (3)  ·  Disruptive, Impulse Control, and Conduct Disorders (2)  ·  Mental Disorders (2)  ·  Health Behavior (1)  ·  Patient Acceptance of Health Care (1)  ·  Treatment Adherence and Compliance (1)

Interventions

Naloxone (1)  ·  Naltrexone (1)

Sponsors

Finnish Institute for Health and Welfare (1)  ·  Pro-Change Behavior Systems (1)  ·  University of Sao Paulo (1)

Countries

Finland (1)  ·  United States (1)

Top investigators

Deborah A Levesque, Ph.D. (1)  ·  Hannu Alho, Prof. (1)

Results publications

PMID 36130734

NIH funding

2017 (1)